Edition:
United States

People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

132.55USD
22 Jul 2016
Change (% chg)

$0.59 (+0.45%)
Prev Close
$131.96
Open
$131.81
Day's High
$134.69
Day's Low
$131.58
Volume
308,134
Avg. Vol
390,906
52-wk High
$138.93
52-wk Low
$71.63

Berkman, Charles 

Mr. Charles S. Berkman J.D., serves as Vice President, General Counsel, Secretary of Ligand Pharmaceuticals Incorporated since April 2007. Berkman joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker & McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon & Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a BS in chemistry from the University of Texas and a JD from the University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD 404,649
Restricted Stock Awards, USD 186,050
Long-Term Incentive Plans, USD --
All Other, USD 964,216
Fiscal Year Total, USD 1,554,920

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 56,198 1,742,700.00